IL17A and cancer: Interleukin 17A (IL-17A), the major cytokine secreted by Th17, is known to promote CRC progression via both immune and cancer modulation mechanisms (Hurtado et al, 2018; Razi et al, 2019; Tosolini et al, 2011).